EU approves SCA's sale of clinical products

|
|

The EU competition authority has approved the divestment of the clinical products division of the Swedish forest products group SCA via its subsidiary SCA Mölnlycke. According to SCA the purchase price amounts to approximately SKr1.5bn. The agreement provides for SCA acquiring Tamro's operations in the incontinence ...

Read more

You can only use this article with a valid subscription and registration. Registered subscribers can access all articles after entering their user name and password.
- Ad -

Article categories
- Ad -